Rubicon Organics to Report Q4 2024 Results
VANCOUVER, British Columbia, March 18, 2025 (GLOBE NEWSWIRE) — Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the […]
Canadian Net REIT Announces 2024 Fourth-Quarter Results
MONTRÉAL, March 18, 2025 (GLOBE NEWSWIRE) — Canadian Net Real Estate Investment Trust (“Canadian Net” or the “REIT”) (TSX-V: NET.UN) […]
Avante Launches WALL-E: A Mobile, AI-Powered Security Tower for Remote and High-Risk Locations
WALL-E is an unmanned, solar-powered security tower integrating Avante’s Halo technology for real-time threat detection, leveraging AI video analytics and […]
Independent Survey Confirms Public Support for Falco Horne 5 Project
MONTRÉAL, March 18, 2025 (GLOBE NEWSWIRE) — Falco Resources Ltd. (TSX.V: FPC) (“Falco” or the “Company”) is pleased to publish […]
Cornish Metals Announces Results of Special Meeting of Shareholders
THIS ANNOUNCEMENT IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES. THIS ANNOUNCEMENT IS […]
Volatus Aerospace Leads the Conversation: Navigating Geopolitical Shifts & Strategic Partnerships for Future Growth
MONTREAL, March 18, 2025 (GLOBE NEWSWIRE) — Volatus Aerospace Inc. (TSXV: FLT) (OTCQX: TAKOF) (Frankfurt: A2JEQU) (“Volatus” or “the Company”) […]
NEO Battery Showcases Mass-Producible Silicon Battery Prototype with Highest Capacity Retention Achieved to Date
TORONTO, March 18, 2025 (GLOBE NEWSWIRE) — NBMSiDE® P-300N: Advanced Prototype for Mass-Producibility Testing with Highest Capacity Retention Achieved to […]
Omega Laboratories Reports Completion of Method Validation with Cannabix Technologies Inc. for Marijuana Breath Detection
VANCOUVER, British Columbia, March 18, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the […]
VVC Appoints New President & Grants Options
TORONTO, March 18, 2025 (GLOBE NEWSWIRE) — VVC Exploration Corporation, dba VVC Resources, (“VVC”), (TSX-V:VVC and OTCQC:VVCVF) announces the following: […]
Clearmind Medicine Announces Initiation of First in Human Clinical Trial with CMND-100 in Alcohol Use Disorder Patients
Study represents the first clinical application of CMND-100, the Company’s proprietary drug platform Vancouver, Canada, March 18, 2025 (GLOBE NEWSWIRE) […]
